Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Sumitomo Chemical India Ltd (SUMICHEM)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 542920 NSE: SUMICHEM Pesticides & Agrochemicals | Small Cap | Sumitomo Chem. India Share Price
₹477 -4.35 (-0.90%)
As on 11-Sep'26 16:59
Sumitomo Chemical India Ltd (SUMICHEM)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 542920 NSE: SUMICHEM Pesticides & Agrochemicals | Small Cap | Sumitomo Chem. India Share Price
₹477 -4.35 (-0.90%)
As on 11-Sep'26 16:59
Key Metrics
Valuation Multiples
Market Cap
₹23,809 Cr.
Current Price
₹477
52-Week Low / High
₹363 / 618
TTM EPS
₹11.6
TTM Sales
₹3,245 Cr.
Book Value per Share
₹72.2
P/E Ratio
41.09
Lower than its 5-year historical median
Industry PE
29
Price to Book (P/B)
6.61
Lower than its 5-year historical median
Price to Sales (P/S)
7.34
In line with its 5-year historical median
EV/EBITDA
28.20
Lower than its 5-year historical median
Dividend Yield
0.27%
Profitability Efficiency
Return on Equity (ROE)
17.26%
Outperforms industry median
Return on Capital Employed (ROCE)
23.39%
Outperforms industry median
Return on Assets (ROA)
12.87%
Operating Profit Margin
19.5%
Net Profit Margin
16.77%
Gross Profit Margin
22.5%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
3.09%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
-0.16%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
7.22%
Asset Quality
Promoter Holding
75.00%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹3,105 Cr.
Equity
₹499.2 Cr.
Face Value
₹10
All Time Low / High
₹152.50 / 665.00
Check Before You Invest
Quality
Very GoodValuation
Somewhat UndervaluedCheck Valuation charts
Price Trend
Weak
Is Sumitomo Chemical India Ltd a good quality company?
Sumitomo Chemical India Ltd is a good quality company, based on a consistently good multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Sumitomo Chemical India Ltd performance compare with that of its Peers?
Revenue growth of Sumitomo Chemical India Ltd vs industry peers?
Sumitomo Chemical India Ltd revenue CAGR is 4.13%, compared to the industry median CAGR of 0.66%, indicating faster growth and gaining its market share.
Promoter shareholding and pledge status of Sumitomo Chemical India Ltd?
Promoters hold 75.00% of the Sumitomo Chemical India Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Sumitomo Chemical India Ltd over the last decade?
Over the last 5 year(s), the stock has delivered a CAGR of 2.88% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Sumitomo Chemical India Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good
Value Creation ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 20.9% | 26.9% | 26.2% | 24.2% | 33.6% | 34.4% | 30.7% | 21.1% | 25.5% | 23.4% | - |
| Value Creation Index ⓘ | 0.9 | 1.4 | 1.3 | 0.8 | 1.5 | 1.6 | 1.7 | 0.6 | 1.3 | 1.1 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 799 | 1,911 | 2,223 | 2,423 | 2,643 | 3,060 | 3,511 | 2,833 | 3,090 | 3,186 | 3,192 |
| Sales YoY Gr. | - | 139.3% | 16.3% | 9% | 9.1% | 15.8% | 14.7% | -19.3% | 9.1% | 3.1% | - |
| Adj EPS ⓘ | 2.4 | 5.3 | 6.4 | 4.6 | 6.9 | 8.6 | 10.2 | 7.4 | 10.1 | 11 | 11.6 |
| YoY Gr. | - | 126.3% | 20.2% | -28.5% | 49.5% | 25.5% | 18% | -27.2% | 35.8% | 9.8% | - |
| BVPS (₹) ⓘ | 26.7 | 26 | 29.5 | 24.2 | 30.6 | 38.6 | 47.7 | 48.9 | 58 | 67.8 | 72.1 |
| Adj Net Profit ⓘ | 64.7 | 147 | 176 | 229 | 343 | 430 | 507 | 369 | 502 | 551 | 580 |
| Cash Flow from Ops. ⓘ | -20.9 | 48.8 | 74.8 | 222 | 425 | 223 | 389 | 756 | 458 | 443 | - |
| Debt/CF from Ops. ⓘ | 0 | 0.2 | 0.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 16.6% | 3.8% | -3.2% | 3.1% | ||||
| Adj EPS ⓘ | 18.7% | 10% | 2.8% | 9.8% | ||||
| BVPSⓘ | 10.9% | 17.2% | 12.5% | 16.8% | ||||
| Share Price | - | 2.9% | 3.9% | -14% | ||||
Key Financial Parameters ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 12.6 | 17.6 | 17.9 | 20.4 | 25 | 24.9 | 23.6 | 15.3 | 18.8 | 17.5 | 16.6 |
| Op. Profit Mgn % ⓘ | 13.2 | 11.6 | 13.3 | 14 | 18.6 | 19.7 | 19 | 16.7 | 20.2 | 20.9 | 21.3 |
| Net Profit Mgn % ⓘ | 8.1 | 7.7 | 7.9 | 9.5 | 13 | 14 | 14.4 | 13 | 16.2 | 17.3 | 18.2 |
| Debt to Equity ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Working Cap Days ⓘ | 211 | 172 | 206 | 208 | 205 | 205 | 206 | 256 | 265 | 277 | 197 |
| Cash Conv. Cycle ⓘ | 102 | 76 | 89 | 93 | 93 | 96 | 97 | 103 | 80 | 87 | 138 |
Valuation of Sumitomo Chem. India - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,913 | 2,228 | 2,425 | 2,645 | 3,061 | 3,511 | 2,844 | 3,149 | 3,238 |
| Operating Expenses ⓘ + | 1,693 | 1,938 | 2,090 | 2,157 | 2,459 | 2,850 | 2,369 | 2,516 | 2,607 |
| Operating Profit ⓘ | 220 | 291 | 335 | 488 | 602 | 661 | 475 | 633 | 632 |
| Operating Profit Margin (%) | 11.5% | 13.0% | 13.8% | 18.5% | 19.7% | 18.8% | 16.7% | 20.1% | 19.5% |
| Other Income ⓘ + | 30 | 8 | 11 | 19 | 27 | 51 | 96 | 120 | 186 |
| Interest ⓘ | 5 | 4 | 7 | 7 | 8 | 6 | 6 | 7 | 8 |
| Depreciation ⓘ | 24 | 28 | 41 | 47 | 45 | 52 | 62 | 66 | 66 |
| Profit Before Tax ⓘ | 221 | 260 | 267 | 453 | 576 | 654 | 503 | 680 | 728 |
| Tax ⓘ | 76 | 94 | 62 | 108 | 152 | 152 | 133 | 174 | 185 |
| Profit After Tax | 145 | 166 | 205 | 345 | 424 | 502 | 370 | 506 | 543 |
| PAT Margin (%) | 7.6% | 7.4% | 8.4% | 13.1% | 13.8% | 14.3% | 13.0% | 16.1% | 16.8% |
| Adjusted EPS (₹) | 5.3 | 6.0 | 4.1 | 6.9 | 8.5 | 10.1 | 7.4 | 10.1 | 10.9 |
| Dividend Payout Ratio (%) | 0% | 37.90% | 13.40% | 11.60% | 11.80% | 11.90% | 79.70% | 11.90% | 12% |
| PARTICULARS | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 729 | 824 | 1,222 | 1,541 | 1,927 | 2,382 | 2,442 | 2,901 | 3,390 | ||
| Debt + | 10 | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 4 | 4 | ||
| Trade Payables | 527 | 481 | 491 | 591 | 517 | 490 | 430 | 489 | 397 | ||
| Others Liabilities ⓘ | 392 | 536 | 392 | 539 | 565 | 497 | 438 | 569 | 682 | ||
| Total Liabilities ⓘ | 1,658 | 1,860 | 2,105 | 2,672 | 3,010 | 3,369 | 3,313 | 3,963 | 4,474 | ||
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 267 | 279 | 319 | 309 | 390 | 430 | 563 | 556 | 577 | ||
| CWIP ⓘ | 9 | 8 | 10 | 14 | 35 | 71 | 23 | 28 | 20 | ||
| Investments ⓘ | 0 | 0 | 86 | 290 | 356 | 239 | 346 | 524 | 1,153 | ||
| Inventories | 609 | 681 | 588 | 754 | 938 | 889 | 610 | 704 | 766 | ||
| Trade Receivables | 552 | 671 | 850 | 848 | 843 | 946 | 716 | 783 | 736 | ||
| Cash Equivalents | 74 | 51 | 94 | 242 | 79 | 303 | 183 | 43 | 121 | ||
| Others Assets ⓘ | 147 | 170 | 158 | 213 | 368 | 491 | 872 | 1,324 | 1,102 | ||
| Total Assets ⓘ | 1,658 | 1,860 | 2,105 | 2,672 | 3,010 | 3,369 | 3,313 | 3,963 | 4,474 | ||
| PARTICULARS | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 47 | 78 | 221 | 425 | 222 | 389 | 757 | 452 | 446 |
| Cash Flow From Investing Activity ⓘ + | -40 | -35 | -118 | -283 | -290 | -327 | -420 | -392 | -332 |
| Cash Flow From Financing Activity ⓘ + | 7 | -65 | -61 | -47 | -63 | -73 | -337 | -68 | -83 |
| Net Cash Flow ⓘ | 15 | -23 | 42 | 96 | -131 | -10 | -0 | -8 | 31 |
| PARTICULARS | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 19.89 | 21.35 | 20.01 | 25 | 24.42 | 23.31 | 15.33 | 18.96 | 17.26 | |
| ROCE (%) | 23.48 | 25.94 | 23.9 | 33.31 | 33.66 | 30.65 | 21.09 | 25.71 | 23.39 | |
| Asset Turnover Ratio | 1.18 | 1.43 | 1.38 | 1.27 | 1.24 | 1.24 | 0.97 | 0.96 | 0.85 | |
| PAT to CFO Conversion(x) | 0.32 | 0.47 | 1.08 | 1.23 | 0.52 | 0.77 | 2.05 | 0.89 | 0.82 | |
| Working Capital Days | ||||||||||
| Receivable Days | 102.70 | 89 | 101.60 | 102.20 | 87.60 | 82.40 | 94.10 | 78.40 | 77.10 | |
| Inventory Days | 113.40 | 93.90 | 84.70 | 80.80 | 87.60 | 84.10 | 84.80 | 68.70 | 74.60 | |
| Payable Days | 175.80 | 142.70 | 120.70 | 132.90 | 117.20 | 88.90 | 102.70 | 100 | 95.90 | |
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Sumitomo Chemical India Ltd FAQs
The current trading price of Sumitomo Chem. India on 11-Sep-2026 16:59 is ₹477.0.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 10-Sep-2026 the market cap of Sumitomo Chem. India stood at ₹23,809.3 Cr
The latest P/E ratio of Sumitomo Chem. India as of 10-Sep-2026 is 41.06.
The latest P/B ratio of Sumitomo Chem. India as of 10-Sep-2026 is 6.61.
The 52-week high of Sumitomo Chem. India is ₹617.5 and the 52-week low is ₹363.3.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Sumitomo Chem. India is ₹3,192 ( Cr.) .
Past 10 year's financial track record analysis by Moneyworks4me indicates that Sumitomo Chemical India Ltd is a good quality company.
The key valuation ratios of Sumitomo Chemical India Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Sumitomo Chemical India Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About Sumitomo Chemical India Ltd
Sumitomo Chemical India (SCIL) is a listed subsidiary of Sumitomo Chemical Company, Japan (SCC), one of the world’s renowned global chemical companies, and is listed on the NSE and BSE.
SCIL is a leading manufacturer and distributor of diverse agro-solutions, environmental health, and animal nutrition products. The company has achieved remarkable growth over the years through its strategic and operational endeavours. Designed to meet the agricultural needs of farmers and communities worldwide, its offerings span crop protection, storage pest control, rodent control, biopesticides, plant growth regulators, and more.
With state-of-the-art manufacturing facilities and robust R&D capabilities, SCIL is committed to producing high-quality agrochemical and nutrition solutions. Its extensive product portfolio includes herbicides, insecticides, fungicides, fumigants, and plant growth regulators. With a strong focus on innovation and sustainability, SCIL remains committed to achieving its objective of becoming a trusted industry player and contributing to sustainable agricultural practices globally.
Business area of the company
The company is primarily engaged in manufacturing and sales of household insecticides, agricultural pesticides, public health insecticides and animal nutrition products.
Business segments of the company
Agro-Solutions Division (ASD)
- Crop Protection: The company has portfolio of insecticides, fungicides, miticides, and herbicides – each designed to address the evolving needs of modern agriculture.
- Biologicals: SCIL leverages its research and development expertise to develop effective, eco-friendly alternatives to conventional agrochemicals.
- Plant Nutrition & Plant Growth Regulators: SCIL delivers an advanced portfolio of Biorationals, Plant growth regulators and Crop nutrition products, scientifically formulated to support key physiological processes, enhance biomass accumulation, and optimize yield potential.
- Fumigants and Rodenticides: SCIL produces highly effective fumigants and rodenticides designed to minimize post-harvest losses and ensure grain preservation.
Environment Health Division (EHD)
- Household Pesticides: Its exclusive Pest Control Division in India exemplifies its adaptive Approach - developing solutions to ensure efficacy and compliance.
- Animal Nutrition: SCIL distributes methionine-based products that is used as feed additives.
International Business/Exports: SCIL supplies technical grade & formulation products to its distribution partners in different regions across the world.
Milestones
- 2000: Incorporated in India as Environmental Health Division (EHD) (HHI) distribution Company
- 2002: Entered into manufacturing JV with New Chemi Industries
- 2002: Started Agro Solutions Division (ASD) Business
- 2003: Established EHD (Public Health) Business
- 2005: Acquired EHD (HHI) Unit
- 2009: Initiated the Animal Nutrition Segment
- 2011: Acquired New Chemi and integrated it with SCIL.
- 2011: SCIL registered revenue of Rs 2.3 billion
- 2012-15: Set-up new organisation, control system, PCO function and innovative sales team and field promotion activities
- 2016: Acquisition of Excel Crop Care
- 2018: Merger with Excel Crop Care Limited.
- 2018: SCIPL changed to Sumitomo Chemical India Limited (SCIL), post-merger.
- 2019: SCIL was listed on the Bombay Stock Exchange.
- 2020: Commenced SCIL 2.0 - First full year of integrated operations.
- 2020: Recorded revenue of Rs 24.2 billion
- 2023: Achieved highest revenue of Rs 35.11 billion and acquired majority stake in Barrix Agro Sciences Pvt Ltd, engaged in R&D, innovation manufacturing and marketing pheromones and other IPM and IPNM products
- 2025: V-shaped recovery; Highest profitability & Environmental Clearance obtained for Dahej Plant
- 2026: Highest Profitability despite challenging environment.
You have 46 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
